No Travel? No Problem.

Remote Participation
FEP-Based Large-Scale Virtual Screening for Effective Drug Discovery against COVID-19
Event Type
ACM Gordon Bell Finalist
Awards Presentation
Tags
AI-HPC Convergence
Computational Science
Extreme Scale Comptuing
Performance
Scientific Computing
Registration Categories
TP
TimeWednesday, 17 November 20212pm - 2:30pm CST
Location240-241-242
DescriptionAs a theoretically rigorous and accurate method, FEP-ABFE (Free Energy Perturbation-Absolute Binding Free Energy) calculations showed great potential in drug discovery, but its practical application was difficult due to high computational cost. To rapidly discover antiviral drugs targeting SARS-CoV-2 Mpro and TMPRSS2, we performed FEP-ABFE-based virtual screening for ∼12,000 protein-ligand binding systems on a new generation of Tianhe supercomputer. A task management tool was specifically developed for automating the whole process involving more than 0.5 million MD tasks. In further experimental validation, 50 out of 98 tested compounds showed significant inhibitory activity towards Mpro, and one representative inhibitor, dipyridamole, showed remarkable outcomes in subsequent clinical trials. This work not only demonstrates the potential of FEP-ABFE in drug discovery, but also provides an excellent starting point for further development of anti-SARS-CoV-2 drugs. Besides, ∼500 TB of data generated in this work will also accelerate the further development of FEP-related methods.
Back To Top Button